Biochemical markers of bone turnover in men

Calcified Tissue International

Volumn 69, Issue 4, 2001, Pages 229-234

  Szulc, P ^a   Delmas, P D ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Bone markers; Bone resorption; Bone turnover; Male osteoporosis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; HYDROXYLYSINE; HYDROXYPROLINE; OSTEOCALCIN; PROCOLLAGEN; PYRIDINOLINE;

AGING; BLOOD ANALYSIS; BONE DENSITY; BONE TURNOVER; CONFERENCE PAPER; FRACTURE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; URINALYSIS;

ADULT; AGED; AGING; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; CLIMACTERIC; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 0034755672     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-001-1059-1     Document Type: Conference Paper

References (43)

1. Biochemical markers of bone turnover. Application for osteoporosis
2. Biochemical markers for the assessement of bone turnover
3. Molecular markers of bone turnover: Biochemical, technical and analytical aspects
4. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease
5. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum
6. Measurement of serum osteocalcin with human-specific two-site immunoradiometric assay
7. Immunoradiometric assay for intact human osteocalcin (1-49) without cross-reactivity to breakdown products
8. Immunoassay for intact aminoterminal propeptide of human type I procollagen
9. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis
10. Urinary excretion of pyridinium crosslinks: A new marker of bone resorption in metabolic bone disease
11. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease
12. Type I collagen C-telopeptide degradation products as bone resorption markers
13. Characterization of urinary degradation products derived from type I collagen. Identification of a β-isomerizes Asp-Gly sequence within the C-terminal telopeptide (α1) region
14. Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: Assessment of bone turnover
15. Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies
16. Relationships of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
17. Age-related changes in bone turnover in men
18. Effect of age on bone density and bone turnover in men
19. Sexual differences in bone markers and bone mineral density of normal Chinese
20. Cross-sectional evaluation of bone metabolism in men
21. Collagen N-telopeptide excretion in men: The effects of age and intrasubject variability
22. The structural basis of bone fragility in men
23. Cross-sectional assessment of age-related bone loss in men: The MINOS study
24. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: Age- and sex-related changes and reference limits
25. High bone turnover in the elderly
26. The renal clearance of free and conjugated pyridinium cross-links of collagen
27. Biochemical parameters associated with low bone mineral density in healthy men and women
28. Risk factors for increased bone loss in an elderly population. The Rotterdam study
29. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density
30. Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women
31. Bone density, bone turnover, and hormone levels in men over age 75
32. Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: The Taiji study
33. Bone mineral density and serum levels of aminoterminal propeptides and cross-linked N-telopeptides of type I collagen in elderly men
34. Biochemical markers and bone mineral density in patients with hip fractures in men
35. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin
36. Alendronate treatment of osteoporosis in men
37. Effects of testosterone replacement in hypogonadal men
38. Effect of testosterone treatment on bone mineral density in men over 65 years of age
39. Androgen supplementation in eugonadal men with osteoporosis: Effects of six months' treatment on markers of bone formation and resorption
40. Treatment of isolated hypogonadotropic hypogonadism. Effect on bone mineral density and bone turnover
41. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men - A clinical research center study
42. Effects of testosterone supplementation in the aging male
43. Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling